ARTV - Artiva Biotherapeutics, Inc.
11.3
-0.430 -3.805%
Share volume: 172,442
Last Updated: 04-23-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.21%
PREVIOUS CLOSE
CHG
CHG%
$11.73
-0.43
-0.04%
View ratios
| Fiscal Date | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 08-29-2024 | 11-12-2024 | 03-24-2025 | 05-08-2025 | 11-12-2025 | 03-10-2026 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | ||||
| Operating expenses | 16.190 M | 18.335 M | 0.000 | 22.171 M | 22.897 M | 21.932 M | |
| Selling general and admin | 3.857 M | 4.811 M | 0.000 | 5.119 M | 5.264 M | 4.938 M | |
| Research and development | 12.333 M | 13.524 M | 0.000 | 17.052 M | 17.633 M | 16.994 M | |
| Total expenses | 16.190 M | 18.335 M | 0.000 | 22.171 M | 22.897 M | 21.932 M | |
| 13.25% | -100.00% | 3.27% | -4.21% | ||||
| Operating income | -16.190 M | -18.335 M | 0.000 | -22.171 M | -22.897 M | -21.932 M | |
| Ebit | -18.542 M | -19.312 M | 0.000 | -22.171 M | -22.897 M | -21.932 M | |
| Pretax income | -17.866 M | -17.466 M | 0.000 | -20.307 M | -21.525 M | -20.770 M | |
| -2.24% | -100.00% | 6.00% | -3.51% | ||||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -17.843 M | -17.472 M | 0.000 | -20.311 M | -21.528 M | -20.772 M | |
| 2.08% | 100.00% | -5.99% | 3.51% |